Abnormal expression of KIF20A has been observed in various cancers, including breast, pancreatic, glioma, hepatocellular carcinoma, esophageal squamous cell carcinoma, bladder, and prostate cancers [77,78]. Here, KIF20A is linked to hepatocellular carcinoma.